Altered Blood Pressure Progression in the Community and Its Relation to Clinical Events | Cardiology | JAMA Internal Medicine | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Original Investigation
July 14, 2008

Altered Blood Pressure Progression in the Community and Its Relation to Clinical Events

Author Affiliations

Author Affiliations: Framingham Heart Study, Framingham, Massachusetts (Drs Ingelsson, Gona, Larson, Kannel, Vasan, and Levy); Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden (Dr Ingelsson); Departments of Mathematics and Statistics (Drs Gona and Larson), and Preventive Medicine, Cardiology Section, Boston University School of Medicine (Drs Vasan and Levy), Boston, Massachusetts; Department of Preventive Medicine and Bluhm Cardiovascular Institute, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois (Dr Lloyd-Jones); and Center for Population Studies of the National Heart, Lung, and Blood Institute, Bethesda, Maryland (Dr Levy). Dr Ingelsson is now with the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Arch Intern Med. 2008;168(13):1450-1457. doi:10.1001/archinte.168.13.1450

Background  Long-term blood pressure (BP) progression and its importance as a predictor of clinical outcome have not been well characterized across different periods.

Methods  We evaluated period trends for 3 BP variables (long-term slope and mean BP during a baseline period of 16 years, and last baseline value) in an earlier period (1953-1971; n = 1644, mean participant age, 61 years) and in a later period (1971-1990; n = 1040, mean participant age, 58 years) in participants in the Framingham Heart Study who initially did not have hypertension. In addition, we explored the relation of BP to cardiovascular disease incidence and all-cause mortality in the 2 periods, each with up to 16 years of follow-up.

Results  Long-term slope, mean, and last baseline BP measurements were significantly lower in the later period (P < .001). Rates of hypertension control (BP <140/90 mm Hg) were higher in the later vs the earlier period (32% vs 23%; P < .001). Multivariate hazard ratios for the relation of BP to outcomes were generally lower in the later period; this was statistically significant for the relation of last baseline BP to all-cause mortality (hazard ratio for 1-SD increase in systolic BP, 1.02 vs 1.25, P = .03; hazard ratio for diastolic BP, 1.00 vs 1.23, P = .04).

Conclusions  We found evidence that BP levels in the community have changed over time, coinciding with improved rates of hypertension control and attenuation of BP-mortality relations. These findings are consistent with the hypothesis that hypertension treatment in the community has altered the natural history of BP progression and its relation to clinical outcome.